Branched Stent Grafts Market Size

Global Branched Stent Grafts Market size was valued at USD 324.39 Million in 2023 and is poised to grow from USD 349.37 Million in 2024 to USD 632.42 Million by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032). 

The branched stent graft was invented to treat aortic lesions. It will be used in the EVAR of pectoral aneurysm and arterial dissection, and it expands the use of the EVAR of pectoral aneurysm and arterial dissection from within the aorta to within each aorta and aorta. Increases in the number of endovascular cardiovascular disease repair (EVAR) procedures, improvements in patient care quality, and advancements in medical technology are major driving factors in the branched stent grafts market. Furthermore, the growing geriatric population, as well as the high prevalence of aortic aneurysm or abdominal aneurysm, are driving the growth of the branched stent grafts market.

However, the occurrence of the novel coronavirus and subsequent pandemic hampered the event of the global branched stent grafts market due to a decline in sales, a reduction in rate of growth, and the postponement of elective surgeries. And the growing demand for minimally invasive surgical procedures is also expected to provide numerous opportunities for the branched stent grafts market.

US Branched Stent Grafts Market is poised to grow at a sustainable CAGR for the next forecast year.